AN2 Therapeutics is betting on three Phase 2 programs, but can its boron pipeline deliver after epetraborole’s MAC setback?
AN2 Therapeutics is advancing three Phase 2 programs as epetraborole moves into PV and AN2-502998 approaches a Chagas proof-of-concept test.